Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases-Reference-Cited by-同舟云学术

Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases

Published:2019-09 Issue:10203 Volume:394 Page:1041-1054
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Strongman Helen,Gadd Sarah,Matthews Anthony,Mansfield Kathryn E,Stanway Susannah,Lyon Alexander R,dos-Santos-Silva Isabel,Smeeth Liam,Bhaskaran Krishnan

Funder

Wellcome Trust

Publisher

Elsevier BV

Subject

General Medicine

Reference40 articles.

1. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology;Zamorano;Eur Heart J,2016

2. Shared risk factors in cardiovascular disease and cancer;Koene;Circulation,2016

3. Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1;Chang;J Am Coll Cardiol,2017

4. Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 2;Chang;J Am Coll Cardiol,2017

5. Cardiovascular disease in survivors of childhood cancer: insights into epidemiology, pathophysiology, and prevention;Armenian;J Clin Oncol,2018

Cited by 327 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma proteomes of acute myeloid leukemia patients treated with transfusions reveal signatures of inflammation and hemostatic dysregulation;Translational Medicine Communications;2024-09-09

2. Thrombotic events associated with immune checkpoint inhibitors and novel antithrombotic strategies to mitigate bleeding risk;Blood Reviews;2024-09

3. Associations between Life's Essential 8 and risks of all-cause and cardiovascular mortality in cancer survivors: A prospective cohort study from NHANES;Heliyon;2024-09

4. Comorbidity trajectories before and after the diagnosis of heart failure: a UK Biobank cohort study;2024-08-28

5. Cardiovascular death risk in patients with solid tumors: a population-based study in the United States;European Journal of Cancer Prevention;2024-08-26